Epizyme (EPZM) Tops Q3 EPS by 18c

Epizyme (NASDAQ: EPZM) reported Q3 EPS of ($0.42), $0.18 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $6.6 million.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15